+38 (097) 836 32 48

 Biofoodpharm

  • Ukraine
  • South Korea
  • Germany
  • USA

Opening new markets together

>  News

The government promulgated its Resolution No. 324 of April 7, 2021, according to which cannabis-based drugs - "Nabilon", "Nabiximols" and "Dronabinol" are excluded from the list of prohibited for circulation in Ukraine.
This is the first such step to legalize cannabinoid-based drugs in Ukraine for medical purposes.
This decision was quite unexpected, since the discussion about the need to legalize these drugs in Ukraine for use in the form of drugs has been going on for several years. In many European countries, these substances have long been used to mitigate the side effects of chemotherapy and to relieve pain in critically ill patients.
 

Today "Biofoodpharm" celebrates 8 years from the date of creation!
The company's management expresses gratitude to our entire team for their high professionalism, well-coordinated work and together they walked the path through hardships to the stars!
Let each next year of our successful work take our company to the next level of development.
We wish that high productivity, well-coordinated actions, responsibility, enthusiasm of all of you, dedication and high ambitions are always rewarded with huge profits, as well as stability and gratitude of all our customers.
Thanks to all our employees, clients and partners for many years of successful cooperation!
Happy foundation, Biofoodpharm!

Dear partners, colleagues, clients, friends!
Biofoodpharm congratulates you and your families on
Happy New Year and Merry Christmas !!!
May the light of the Christmas star bring you health, peace, prosperity, warmth of human relations and an excellent environment for the development of your business!
Professional growth, new strategically important partners and successful contracts! The contribution of each of you to our difficult task is priceless. Our company congratulates you and wishes you success and prosperity in the New Year!
Happy New Year!
Merry Christmas!!!

The team of Biofoodpharm congratulates our partner and CEO of the company, Nataliia Khomenko, on receiving the award as a finalist of the Medical and Pharmaceutical Law practice of the Attorney of the Year 2020 competition.

The whole team is pleased to work with such a professional as you!

We are proud and wish you new interesting things and well-deserved victories !!!

On August 16, 2020, the Law of Ukraine No. 816-IX came into force, which improves the protection of intellectual property rights to inventions and utility models and adapts patent legislation to EU law.
In particular, the document expands the list of rights and obligations of subjects of rights to inventions / utility models and the list of technology objects that are not subject to legal protection. It also provides for the possibility of filing applications in electronic form and provides the right to file objections to applications for inventions after their publication.
In addition, the procedure for granting additional protection of rights to inventions of medicines is being clarified. Also, by this law, Section VI of the Law of Ukraine "On the Protection of Rights to Inventions and Utility Models" was supplemented by a new Article 27-1, which regulates additional protection of rights to inventions.
This article provides that the owner of a patent for an invention, the object of which is the active substance of a medicinal product, the process of obtaining a medicinal product or using a medicinal product, an animal protection product, a plant protection product, the introduction of which in Ukraine is provided by the competent authority in accordance with the legislation of Ukraine, has the right to extend the period of validity of intellectual property rights to such an invention (additional protection), which is certified by a certificate of additional protection. The Supplementary Protection Certificate is issued at the request of the patent owner with payment of a fee.
Rights to additional protection are limited to a product (active substance or a set of active pharmaceutical ingredients of a medicinal product), the introduction of which into circulation in Ukraine is permitted by the competent authority, and its use in accordance with the quality of the medicinal product, animal protection products, plant protection products within the scope of the rights granted the relevant patent on the day of filing the application for a subsidiary protection certificate, and are valid subject to the validity of such permission.
The owner of a patent for an invention, the object of which is a medicinal product, animal protection product, plant protection product, has the right to extend the period of validity of intellectual property rights in the event that an application for obtaining permission from the competent authority for the introduction of a medicinal product, animal protection product, protection product plants for civil circulation in Ukraine were filed within one year from the date of filing such an application for the first time in any country.
The article also establishes that the term of supplementary protection is equal to the period between the date of filing an application with the institution and the date of receipt by the patent holder of the first authorization from the competent authority, reduced by five years. The term of supplementary protection may not exceed five years. For an invention, the object of which is an active substance of a medicinal product, in respect of which studies have been carried out in the field of use for children, the terms of additional protection shall last for six months.
A person who intends to manufacture a product or a medicinal product containing a product using a patented invention during the period of supplementary protection shall notify the institution and the holder of the supplementary protection certificate of such intention in writing no later than three months before the start of the use of the invention. The applicant's message shall indicate his address, methods of using the invention and the purpose of such use, the number and date of issue of the subsidiary protection certificate.

In the case of the manufacture of a product or a medicinal product containing a product for the purpose of export, the message shall also indicate the number of the authorization of the competent authority of the third country in which the export is planned. The institution ensures the publication of the information contained in the message.
The amendments also provide that the manufacturer of a product or medicinal product containing a product is obliged to obtain written guarantees from all persons who, on his order, store, export or perform other actions that are not recognized as a violation of the rights to an invention, that such a product or the medicinal product containing the product will not be used otherwise than for export or storage in accordance with the established procedure.
The law also provides for an administrative procedure for invalidating the right to an invention or utility model (post grant opposition), which will quickly stop the activity of unfair patent holders, the so-called "patent trolls".

Our partners